Showing results (1951-1960 of 2,037) with videos related to

Sort By:
Pageof 204
Nature Communications|October 14, 2025
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panelsKyle T Helzer, Marina N Sharifi, Jamie M Sperger, et al.
European Urology Oncology|July 12, 2025
Efficacy of Anti-PD-(L)1 Immunotherapy in Patients with DNA Mismatch Repair-deficient Metastatic Castration-resistant Prostate CancerSandra van Wilpe, Tarek Taha, Emily C Rothmann, et al.
Plos Medicine|July 23, 2014
Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysisGiovanni Musso, Roberto Gambino, James H Tabibian, et al.
Journal of Hepatology|October 9, 2020
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry studyThomas Marjot, Andrew M Moon, Jonathan A Cook, et al.
Research Square|May 3, 2023
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate CancerDaniel E Spratt, Siyi Tang, Yilun Sun, et al.
Neurobiology of Aging|March 15, 2016
The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volumeMichelle K Lupton, Lachlan Strike, Narelle K Hansell, et al.
JBMR Plus|February 5, 2026
Time to reframe osteoporosis: a position statement to characterize the osteoporosis care gapZoe Paskins, Laurna Bullock, Ashley Hawarden, et al.
NEJM Evidence|February 6, 2024
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate CancerDaniel E Spratt, Siyi Tang, Yilun Sun, et al.
European Urology Open Science|December 22, 2021
Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical ProstatectomyKaren A Autio, Emmanuel S Antonarakis, Tina M Mayer, et al.
Science Translational Medicine|December 6, 2019
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancerYanjing Li, Yiping He, William Butler, et al.
Pageof 204